Emerging Microbes & Infections

Article	Citations
The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron	296
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells	295
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost	281
Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case–control real-world study	197
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic	197
SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species	166
Antibody titres decline 3-month post-vaccination with BNT162b2	139
Thein vitroantiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor	127
Emergence and spread of novel H5N8, H5N5 and H5N1 clade 2.3.4.4 highly pathogenic avian influenza in 2020	123
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates	117
Genotype I African swine fever viruses emerged in domestic pigs in China and caused chronic infection	114
Susceptibility of rabbits to SARS-CoV-2	104
Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters	101
Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies	98
Lessons learned from the fifth wave of COVID-19 in Hong Kong in early 2022	83
Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients	79
African swine fever control and prevention: an update on vaccine development	77
Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine	76
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	71
Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge	69
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study	68
A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners	67
Alarming situation of emerging H5 and H7 avian influenza and effective control strategies	64
Infection and transmission of ancestral SARS-CoV-2 and its alpha variant in pregnant white-tailed deer	64
Global dissemination of H5N1 influenza viruses bearing the clade 2.3.4.4b HA gene and biologic analysis of the ones detected in China	61

Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system	59
Metformin attenuated sepsis-related liver injury by modulating gut microbiota	58
A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates	57
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies	57
Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine	56
Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis	54
Novel H5N6 reassortants bearing the clade 2.3.4.4b HA gene of H5N8 virus have been detected in poultry and caused multiple human infections in China	53
High estradiol and low testosterone levels are associated with critical illness in male but not in female COVID-19 patients: a retrospective cohort study	52
Confirmation of fifth Candida auris clade by whole genome sequencing	52
Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission	52
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2	51
Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture	50
Molecular epidemiology of carbapenem-resistant hypervirulent Klebsiella pneumoniae in China	50
Resistance evolution of hypervirulent carbapenem-resistant Klebsiella pneumoniae ST11 during treatment with tigecycline and polymyxin	49
Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study	49
Experimental re-infected cats do not transmit SARS-CoV-2	47
SARS-CoV-2 reinfection and COVID-19 severity	46
The interplay between emerging human coronavirus infections and autophagy	45
COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue	45
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern in real-world: a literature review and meta-analysis	44
Plasma miRNA profile at COVID-19 onset predicts severity status and mortality	44
Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection	44
Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications	43
Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor	43
An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants	42
Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated hospitalized children: comparison to influenza and parainfluenza infections	42
Comparative pathogenicity and environmental transmission of recent highly pathogenic avian influenza H5 viruses	41
Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster	41
Co-circulation of two SARS-CoV-2 variant strains within imported pet hamsters in Hong Kong	41
Susceptibility of livestock to SARS-CoV-2 infection	41
Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection	40
The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants	39
Aetiology of severe community acquired pneumonia in adults identified by combined detection methods: a multi-centre prospective study in China	39
Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study	39
Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial	39
Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents	38
Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave	38
A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques	37
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV	37
Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort	37
Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022	36
The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract	35
A novel SARS-CoV-2 related coronavirus with complex recombination isolated from bats in Yunnan province, China	35
Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study	35
Methicillin-resistant Staphylococcus aureus in China: a multicentre longitudinal study and whole-genome sequencing	35
Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study	34
Infections with highly pathogenic avian influenza A virus (HPAIV) H5N8 in harbor seals at the German North Sea coast, 2021	34
Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response	33
Molecular characterization of carbapenem-resistant and virulent plasmids in Klebsiella pneumoniae from patients with bloodstream infections in China	33
Comprehensive literature review of monkeypox	33

Prevalence of hypervirulent and carbapenem-resistant Klebsiella pneumoniae under divergent evolutionary patterns	32
SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay	32
Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model	32
Antibodies to SARS-CoV-2 in dogs and cats, USA	32
Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France	30
Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants	30
Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma	30
Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification	30
Molecular characterization, receptor binding property, and replication in chickens and mice of H9N2 avian influenza viruses isolated from chickens, peafowls, and wild birds in eastern China	29
Metagenomic next-generation sequencing in the family outbreak of psittacosis: the first reported family outbreak of psittacosis in China under COVID-19	28
Increasing prevalence of hypervirulent ST5 methicillin susceptible Staphylococcus aureus subtype poses a serious clinical threat	28
Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection	28
Dissemination and genome analysis of high-level ceftriaxone-resistant penA 60.001 Neisseria gonorrhoeae strains from the Guangdong Gonococ	28
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response	28
The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China	28
Compensatory effects of M. tuberculosis rpoB mutations outside the rifampicin resistance-determining region	27
Safety, mucosal and systemic immunopotency of an aerosolized adenovirus-vectored vaccine against SARS-CoV-2 in rhesus macaques	27
Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coron	26
Possible recombination between two variants of concern in a COVID-19 patient	26
Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants	26
Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021	26
Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients	26
Metabolomic analysis reveals potential biomarkers and the underlying pathogenesis involved in Mycoplasma pneumoniae pneumonia	26
Direct neuronal infection of SARS-CoV-2 reveals cellular and molecular pathology of chemosensory impairment of COVID-19 patients	25
Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial	25
Rational development of multicomponent mRNA vaccine candidates against mpox	25
Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis	25
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses	25
SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in an Arf6-dependent manner	25
Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination	25
Emergence of colistin-resistant hypervirulent Klebsiella pneumoniae (CoR-HvKp) in China	24
Mink is a highly susceptible host species to circulating human and avian influenza viruses	24
A new nairo-like virus associated with human febrile illness in China	24
Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine	24
An IncP-2 plasmid sublineage associated with dissemination of blaIMP-45 among carbapenem-resistant Pseudomonas aeruginosa	24
Omicron: a drug developer’s perspective	23
Resistance profiling of Aspergillus fumigatus to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistance	23
Characterization of neurotropic HPAI H5N1 viruses with novel genome constellations and mammalian adaptive mutations in free-living mesocarnivores in Canada	23
Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern	22
Emergence of new phylogenetic lineage of Influenza D virus with broad antigenicity in California, United States	22
Saliva viral load better correlates with clinical and immunological profiles in children with coronavirus disease 2019	22
Human Borna disease virus 1 (BoDV-1) encephalitis cases in the north and east of Germany	22
Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant	22
The prevalence of CRF55_01B among HIV-1 strain and its connection with traffic development in China	22
Genomic and pathogenic investigations of Streptococcus suis serotype 7 population derived from a human patient and pigs	21
COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in Malaysia	21
Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein	21
Genomic epidemiology of Candida auris in a general hospital in Shenyang, China: a three-year surveillance study	21
Novel tigecycline resistance mechanisms in Acinetobacter baumannii mediated by mutations in adeS, rpoB and rrf	21
PB1 S524G mutation of wild bird-origin H3N8 influenza A virus enhances virulence and fitness for transmission in mammals	21
Multiple detection and spread of novel strains of the SARS-CoV-2 B.1.177 (B.1.177.75) lineage that test negative by a commercially available nucleocapsid gene real-time RT-PCR	21
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2	21
Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates	21
Healthy outcomes of patients with COVID-19 two years after the infection: a prospective cohort study	20
Susceptibility of sheep to experimental co-infection with the ancestral lineage of SARS-CoV-2 and its alpha variant	20
A second functional furin site in the SARS-CoV-2 spike protein	20
Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate	20
Real-time monitoring ofPseudomonas aeruginosabiofilm growth dynamics and persister cells’ eradication	20
Understanding the impact of rapid antigen tests on SARS-CoV-2 transmission in the fifth wave of COVID-19 in Hong Kong in early 2022	20
Infection dynamics of Salmonella Infantis strains displaying different genetic backgrounds – with or without pESI-like plasmid – vary considerably	19
Animal alphacoronaviruses found in human patients with acute respiratory illness in different countries.	19
Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge	19
Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3	19
A One Health view of the West Nile virus outbreak in Andalusia (Spain) in 2020	19
Outer membrane vesicles-transmitted virulence genes mediate the emergence of new antimicrobial-resistant hypervirulent Klebsiella pneumoniae	19
Widely heterogeneous humoral and cellular immunity after mild SARS-CoV-2 infection in a homogeneous population of healthy young men	19
Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19	18
Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques	18
Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations	18
Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial	18
Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Bra	18
SARS-CoV-2 IgG seropositivity after the severe Omicron wave of COVID-19 in Hong Kong	18
Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants	17
Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection in vitro	17
Live attenuated coronavirus vaccines deficient in N7-Methyltransferase activity induce both humoral and cellular immune responses in mice	17
Re-emergence of H5N8 highly pathogenic avian influenza virus in wild birds, China	17
Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study	17
RT-LAMP assay for rapid detection of the R203M mutation in SARS-CoV-2 Delta variant	17
Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract	17
Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants	17

Exploring surface water as a transmission medium of avian influenza viruses – systematic infection studies in mallards	17
Three doses of an inactivation-based COVID-19 vaccine induces cross-neutralizing immunity against the SARS CoV-2 Omicron variant	17
Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China	17
Impact of National Omicron Outbreak at the end of 2022 on the future outlook of COVID-19 in China	17
Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants	16
Emergence of the novel SARS-CoV-2 lineage VUI-NP13L and massive spread of P.2 in South Brazil	16
African swine fever virus – variants on the rise	16
The emerging tick-borne pathogen Neoehrlichia mikurensis: first French case series and vector epidemiology	16
The nasopharyngeal microbiome in COVID-19	16
A year living with SARS-CoV-2: an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain)	16
Viromes and surveys of RNA viruses in camel-derived ticks revealing transmission patterns of novel tick-borne viral pathogens in Kenya	16
Epidemiological and genetic characteristics of clinical carbapenem-resistant Acinetobacter baumannii strains collected countrywide from hospital intensive care units (IC	16
Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination	16
Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro	16
The first detection of Anaplasma capra, an emerging zoonotic Anaplasma sp., in erythrocytes	16
Prevalence and risk analysis of mobile colistin resistance and extended-spectrum β-lactamase genes carriage in pet dogs and their owners: a population based cross-sectional study	16
Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled tria	15
Mycobacterium tuberculosisESX-1-secreted substrate protein EspC promotes mycobacterial survival through endoplasmic reticulum stress-mediated apoptosis	15
Viral determinants that drive Enterovirus-A71 fitness and virulence	15
CRISPR/Cas13a-assisted rapid and portable HBV DNA detection for low-level viremia patients	15
Role of ACE2 genetic polymorphisms in susceptibility to SARS-CoV-2 among highly exposed but non infected healthcare workers	15
Oligonucleotide-capped nanoporous anodic alumina biosensor as diagnostic tool for rapid and accurate detection of Candida auris in clinical samples	15
Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1	15
Molecular epidemiology and genotype-specific disease severity of hepatitis E virus infections in Germany, 2010–2019	15
Invasive listeriosis outbreaks and salmon products: a genomic, epidemiological study	15
Introduction and spread of variegated squirrel bornavirus 1 (VSBV-1) between exotic squirrels and spill-over infections to humans in Germany	15
HIV-1 CRF07_BC transmission dynamics in China: two decades of national molecular surveillance	15
Spike protein evolution in the SARS-CoV-2 Delta variant of concern: a case series from Northern Lombardy	15
Isolation of SARS-CoV-2 strains carrying a nucleotide mutation, leading to a stop codon in the ORF 6 protein	15
Berbamine inhibits Japanese encephalitis virus (JEV) infection by compromising TPRMLs-mediated endolysosomal trafficking of low-density lipoprotein receptor (LDLR)	15
Prevalence and transmission characteristics of Listeria species from ruminants in farm and slaughtering environments in China	15
Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses	15
Early treatment of Favipiravir in COVID-19 patients without pneumonia: a multicentre, open-labelled, randomized control study	15
Emergence of oxacillinase-181 carbapenemase-producing diarrheagenic Escherichia coli in Ghana	14
Frequent convergence of mcr-9 and carbapenemase genes in Enterobacter cloacae complex driven by epidemic plasmids and host incompatibility	14
Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS	14
SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors	14
The COVID-19-designated hospitals in China: preparing for public health emergencies	14
Reinfection rate and disease severity of the BA.5 Omicron SARS-CoV-2 lineage compared to previously circulating variants of concern in the Canary Islands (Spain)	14
Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus	14
Where are the RNA vaccines for TB?	14
MCR-1-dependent lipid remodelling compromises the viability of Gram-negative bacteria	14
Highly pathogenic avian influenza (A/H5N1) virus outbreaks in Lesotho, May 2021	14
Generation and characterization of genetically and antigenically diverse infectious clones of dengue virus serotypes 1–4	14
Emergence, prevalence, and evolution of H5N8 avian influenza viruses in central China, 2020	14
Hepatitis B virus nucleocapsid uncoating: biological consequences and regulation by cellular nucleases	14
Trained immunity contributes to the prevention ofMycobacterium tuberculosisinfection, a novel role of autophagy	14
The genetic feature and virulence determinant of highly virulent community-associated MRSA ST338-SCCmec Vb in China	14
The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis	14
A new microtubule-stabilizing agent shows potent antiviral effects against African swine fever virus with no cytotoxicity	14
UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates	14
Genomic characterization of carbapenem-non-susceptible Pseudomonas aeruginosa in Singapore	13
Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020	13
Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV	13
Epidemiology of extrapulmonary tuberculosis among pediatric inpatients in mainland China: a descriptive, multicenter study	13
Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation	13
Trends of pulmonary fungal infections from 2013 to 2019: an AI-based real-world observational study in Guangzhou, China	13
Clade distribution of Candida auris in South Africa using whole genome sequencing of clinical and environmental isolates	13
CqsA/LuxS-HapR Quorum sensing circuit modulates type VI secretion system VflT6SS2 in Vibrio fluvialis	13
Effect of genomic variations in severe fever with thrombocytopenia syndrome virus on the disease lethality	13
Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody	13
Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study	13
Association of capsular polysaccharide locus 2 with prognosis of Acinetobacter baumannii bacteraemia	13
Clinical signs and symptoms associated with WHO severe dengue classification: a systematic review and meta-analysis	13
The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development	13
A novel diagnostic test to screen SARS-CoV-2 variants containing E484K and N501Y mutations	13
High proportion of tuberculosis transmission among social contacts in rural China: a 12-year prospective population-based genomic epidemiological study	13
Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China	13
Two novel human coronavirus OC43 genotypes circulating in hospitalized children with pneumonia in China	13
Maternal CMV seroprevalence rate in early gestation and congenital cytomegalovirus infection in a Chinese population	13
Establishing and applying an adaptive strategy and approach to eliminating malaria: practice and lessons learnt from China from 2011 to 2020	13
Mapping the risk distribution of Borrelia burgdorferi sensu lato in China from 1986 to 2020: a geospatial modelling analysis	13
Evaluation of an I177L gene-based five-gene-deleted African swine fever virus as a live attenuated vaccine in pigs	13
ATP2, The essential P4-ATPase of malaria parasites, catalyzes lipid-stimulated ATP hydrolysis in complex with a Cdc50 β-subunit	13
Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2	13
Host-dependent editing of SARS-CoV-2 in COVID-19 patients	13
Mutations in porin LamB contribute to ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae	13
A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants	13
STAT2-dependent restriction of Zika virus by human macrophages but not dendritic cells	13